NYLON GRAY #3 SY-01 ROYAL BLUE MIDDLE 3 PP FR 8-6 LMS-1000

PINK T825-5-3 BLUE T225-3-3 PP FR 8-6 LMS-1000

PP RED 3% PP GREEN 3% PP FR 8-6 LMS-1000

ABS GRAY 106745 3% ABS GREY 428C 3% PP FR 8-6 LMS-1000

PERIWINKLE 3 BLUE # 4 T-225-3-3 PP FR 8-6 LMS-1000

X S1054A-4-3 X GT-21973-01-3 PP FR 8-6 LMS-1000

Accordingly, we expect first quarter adjusted EPS of $0.68, up 8% from $0.63 in 2023." Webcast Details Avient will host a webcast on Wednesday, February 14, 2024 at 8:00 a.m. See Attachment 3 for a definition and summary of special items.

– February 3, 2020 – At Medical Design and Manufacturing (MD&M) West next week, PolyOne is focusing on helping customers solve February 3, 2020 February 3, 2020

Avient will provide additional details on its 2022 fourth quarter and full year performance and 2023 outlook during its webcast scheduled for 8:00 a.m. Webcast Details Avient will host a webcast on Wednesday, February 15, 2023 at 8:00 a.m. See Attachment 3 for a definition and summary of special items.

KEY CHARACTERISTICS • Manufactured under change control principles beyond CAS number (similar level as MEVOPUR concentrates), reducing risk of change • Free from animal-derived substances and phthalates • Suitable for blown film, injection molding, blow molding and extrusion REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP chapters , including Class VI, a requirement for ophthalmic and nasal drugs - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities - USP and USP light transmission • Registered Drug Master File (Type III) • Food contact compliance established with FDA/EU* APPLICATION BULLETIN CARRIER MATERIAL PIGMENT CONTENT/TYPE LIGHT FASTNESS THERMAL STABILITY PRODUCT CODE HDPE 50% TiO2 8 300°C PH00075525 LLDPE 60% TiO2 8 300°C PL00075542 LLDPE 70% TiO2 8 300°C PL00075545 PP 50% TiO2 8 300°C PP00075717 Healthcare use limitations apply—see below. Without limiting the generality of this statement, Avient products shall not be used in any medical device application intended for: (1) exposure to human tissue or body fluids for 30 days or greater; (2) “plastic” (cosmetic or reconstructive) surgery use; (3) reproductive implants or any birth control device; or (4) any critical component in a permanently (greater than 30 days) implanted medical device that supports or sustains human life.